Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 7/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.42 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22166081 | 1.00 | DNM1 (0.64) | DNM1LMNATSHRALDH1A1PLA2G1B | |
| SCHEMBL29301042 | 1.00 | DNM1 (0.64) | DNM1LMNATSHRALDH1A1PLA2G1B | |
| SCHEMBL20924915 | 1.00 | DNM1 (0.64) | DNM1LMNATSHRALDH1A1PLA2G1B | |
| SCHEMBL8085386 | 1.00 | DNM1 (0.64) | DNM1LMNATSHRALDH1A1PLA2G1B | |
| SCHEMBL2470513 | 1.00 | DNM1 (0.64) | DNM1LMNATSHRALDH1A1PLA2G1B | |
| SCHEMBL19991270 | 1.00 | DNM1 (0.64) | DNM1LMNATSHRALDH1A1PLA2G1B | |
| SCHEMBL22923312 | 0.95 | DNM1 (0.71) | DNM1LMNATSHRALDH1A1PLA2G1B | |
| SCHEMBL9486793 | 0.95 | DNM1 (0.71) | DNM1LMNATSHRALDH1A1PLA2G1B | |
| Hydrochloric Acid SCHEMBL28550883 | 0.93 | DNM1 (0.73) | DNM1LMNATSHRALDH1A1PLA2G1B | |
| SCHEMBL27053562 | 0.93 | DNM1 (0.67) | DNM1LMNATSHRALDH1A1PLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3988537-A1 | BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS | Alnylam Pharmaceuticals, Inc. (US) | 2022-04-27 | — | — | EP | disclosed |